Home > Boards > US OTC > Medical - Drugs >

Eastgate Biotech Corp. (ETBI)

ETBI RSS Feed
Add ETBI Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, Jimmy Swaggert
Search This Board: 
Last Post: 8/7/2020 6:27:26 PM - Followers: 163 - Board type: Free - Posts Today: 0

About EastGate Biotech
EastGate Biotech focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body.

We utilize advanced nanotechnologies and alternative delivery systems that take difficult to deliver compounds and deliver them using our nanotechnology platform which ultimately increase the bioavailability to the body.

Using our methods of delivery provides healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain a healthy lifestyle.

EastGate's wholly owned subsidiary Omni Surgery and Anti-Aging Centre is the first of many surgery centers to come under the Omni umbrella as we plan to roll up existing business under the Omni brand and expand our footprint globally.



   


 

  •  

Contact Information
2203-65 Harbour Square
Toronto, ONT M5J 2L4
Canada
www.eastgatebiotech.com(647) 692-0652info@eastgatepharmaceuticals.com



Share Structure 

Market Cap Market Cap     
5,289,287
07/31/2020

Authorized Shares   
3,000,000,000     
07/01/2020
 
Outstanding Shares
1,057,857,377
07/01/2020














ETBI patents:

US 61/947,678 Title: Pharmaceutical Composition for Transmucosal Delivery

US 61/947,698 Title: Treatment of Diabetes and Metabolic Syndrome

PCT/C2014/000126 Title: Pharmaceutical Composition for Transmucosal Administration of Benzodiazepines

PCT/CA2014/000127 Title: Pharmaceutical Composition For Enhanced Transmucosal Administration of Benzodiazepines


 

Clinical and Scientific Highlights in 2019:  yes

Announced positive Phase II Clinical Results of Insugin, its liquid insulin mouth rinse for Type 2 diabetes patients in Pakistan
Preparation underway for the Phase III Clinical Study of Insugin in Pakistan
Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply;  the terms include free API insulin to be provided to EastGate Biotech for all clinical studies of Insugin
Expands and restructures Joint Venture with its partner in Pakistan to focus on EastGate Biotech as a brand.  The key products of the Joint Venture to be tested, registered and marketed include Insugin for diabetes application, alternative insulin product for Alzheimer’s application and blood plasma-based products, Human Serum Albumin 20% for the Canadian market
Initiated plans to expand its alternative insulin delivery portfolio to apply to the treatment of Alzheimer’s Disease with a desired endpoint of delaying the progression of the disease which is measured in terms of memory loss and improvement in the status of self care

Corporate Highlights: yes

  • Announced the appointment of Bill Abajian as Chief Operating Officer to lead licensing and Marketing Phase of the company’s developments
    Filed 2017 and 2018 Financial Reports

Anticipated Milestones: yes

  • Initiation and completion of Phase III study of Insugin in Pakistan
    Execute licensing agreements in other territories aiming to cover continents;  plan regulatory and clinical path for each of these markets
    Initiate a Proof of Concept study of an alternative insulin product for Alzheimer’s indication
    Plan registration of Human Serum Albumin 20% and regular recombinant human insulin in Canada
    Consider a secondary public listing
    Explore uplisting to a senior exchange

PRESS RELEASES 

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-pakistan-expands-its-collaboration-advancing-development-new-vaccine-against-covid-19/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-discusses-their-phase-3-clinical-trials-and-recent-coronavirus-agreement/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-pakistan-receives-international-marketing-rights-anaferon-approved-coronavirus-treatment-potentially-combat-wuh/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-provides-summary-2019-corporate-and-development-highlights/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-expands-pipeline-alzheimers-disease-using-its-alternative-insulin-delivery-platform/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-expansion-and-restructuring-joint-venture-its-partner-pakistan/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-receives-regulatory-approval-initiate-phase-iii-90-day-clinical-trial-insugin-its-liquid-insulin-mouth-rinse-so/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-corp-otc-etbi-management-interview/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-appointment-bill-abajian-lead-licensing-and-marketing-phase-chief-operating-officer/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-files-application-initiate-phase-iii-clinical-trial-insugin/



   


https://www.otcmarkets.com/stock/ETBI/overview


Skull and crossbones.gif by HaruRyomaru86 on DeviantArt
 
 
ETBI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#14286  Sticky Note skull and crossbones for etbi. see ibox. lucky,mydog 07/31/20 02:37:56 PM
#13621  Sticky Note EastGate Biotech Provides Summary of 2019 Jimmy Swaggert 01/02/20 02:26:52 PM
#14336   ......... Touche. Jimmy Swaggert 08/07/20 06:27:26 PM
#14335   your quote; lucky,mydog 08/07/20 03:09:51 PM
#14334   Wrong again! A 211 DOES NOT get Jimmy Swaggert 08/07/20 03:06:35 PM
#14333   - attorney letter approved and market maker sponsor lucky,mydog 08/07/20 02:30:18 PM
#14332   If Etbi is looking this is what we’d stolles8 08/07/20 02:18:05 PM
#14330   Wrong. My point is the Caveat status Jimmy Swaggert 08/06/20 09:54:15 PM
#14329   once again you are confusing otc markets, which lucky,mydog 08/06/20 09:42:26 PM
#14327   Actually, if they had a letter they would Jimmy Swaggert 08/06/20 09:30:26 PM
#14326   Those filings cost CASH. Jimmy Swaggert 08/06/20 09:28:08 PM
#14325   There is no liquidity - so if they stolles8 08/06/20 06:52:15 PM
#14324   Phase 3 is why I bought 10 million stolles8 08/06/20 06:46:22 PM
#14323   That’s extremely strange Stevexpress 08/06/20 06:09:26 PM
#14322   https://www.crunchbase.com/person/anna-gluskin lucky,mydog 08/06/20 04:59:31 PM
#14321   That is a bit odd, what in the world?? acing58108 08/06/20 04:41:27 PM
#14320   ceo busy pumping out gift cards. what a joke. lucky,mydog 08/06/20 04:39:06 PM
#14319   Bid in for a million at .0026. Chess Master 08/06/20 04:25:30 PM
#14318   You absolutely read my mind! This is all positive. Jimmy Swaggert 08/06/20 04:24:51 PM
#14317   if the company had a no further action lucky,mydog 08/06/20 04:24:32 PM
#14316   Agree with you that this heads into a Chess Master 08/06/20 04:22:08 PM
#14315   What makes you so sure the SEC is Chess Master 08/06/20 04:19:35 PM
#14314   From the opinion letter dated 7/31/2020: Jimmy Swaggert 08/06/20 11:13:31 AM
#14313   Amen to that. Jimmy Swaggert 08/05/20 12:14:47 PM
#14312   Wouldn’t hurt my feelings picked up a good Stevexpress 08/05/20 12:04:49 PM
#14311   Once off the greys with a news release, Jimmy Swaggert 08/05/20 11:58:02 AM
#14310   That opinion letter is the start of the Jimmy Swaggert 08/04/20 10:34:07 PM
#14309   Weird activity last 2 days Stevexpress 08/04/20 07:55:17 PM
#14308   I know exactly what the Grey sheets are Stevexpress 08/03/20 02:56:26 PM
#14307   Trading on the grey sheet has ZERO to Jimmy Swaggert 08/03/20 01:48:07 PM
#14306   I'll buy 260,000 more at those levels! Jimmy Swaggert 08/03/20 01:35:58 PM
#14305   It just took a dump Stevexpress 08/03/20 12:01:57 PM
#14304   That one is trying to get its second Jimmy Swaggert 08/03/20 10:24:52 AM
#14303   Same shit Soli dealing with Stevexpress 08/03/20 09:58:30 AM
#14302   Opened @ .005 20,000 shares Jimmy Swaggert 08/03/20 09:56:43 AM
#14301   Correct. Good thing there was no fraud. Jimmy Swaggert 08/03/20 09:54:25 AM
#14300   no market maker will sponsor a 211 submission lucky,mydog 08/03/20 09:45:31 AM
#14299   I know exactly what it means, that’s what Stevexpress 08/03/20 09:37:05 AM
#14298   Yes. Only on grey sheet until 15c211 Jimmy Swaggert 08/03/20 09:36:15 AM
#14297   Expert market is Greys, where it is now Stevexpress 08/03/20 09:25:45 AM
#14296   Expert market is home until FINRA approves their 211 Jimmy Swaggert 08/03/20 09:11:27 AM
#14294   I Googled "how long does otc disclosure Jimmy Swaggert 08/02/20 09:58:37 PM
#14293   Where is that? Stevexpress 08/02/20 07:32:46 PM
#14292   OTC Markets says 3-5 business days to review Jimmy Swaggert 08/02/20 07:18:47 PM
#14291   After Friday's trading activity, I'm excited to see Jimmy Swaggert 08/02/20 01:32:37 PM
#14290   ETBI clawing its way back to normalcy with Jimmy Swaggert 07/31/20 04:12:14 PM
#14289   Not a bad day for a skull and Jimmy Swaggert 07/31/20 03:58:45 PM
#14288   Trade off @ .005 for the close? Jimmy Swaggert 07/31/20 03:57:58 PM
#14287   ETBI SEC Suspension "because of concerns about the lucky,mydog 07/31/20 03:29:03 PM
#14286   skull and crossbones for etbi. see ibox. lucky,mydog 07/31/20 02:37:56 PM
#14285   When Does Caveat Emptor Get Removed? Jimmy Swaggert 07/31/20 02:31:55 PM
#14284   When a company is current and subscribes to Jimmy Swaggert 07/31/20 02:30:31 PM
PostSubject